A trial analysis in people with mild cognitive impairment identified a blood-marker subgroup with less cognitive decline after lifestyle intervention than in controls…A trial analysis in people with mild cognitive impairment identified a blood-marker subgroup with less cognitive decline after lifestyle intervention than in controls over 18 months.
Who was studied51 people with mild cognitive impairment, 18-month
What changedThinking skills declined less with the lifestyle program than with control care among participants with elevated GFAP and other abnormal biomarkers
The catchThe subgroup was identified and evaluated for intervention benefit within the same cohort
Moderate and severe frailty were linked to 66% and 141% higher odds of developing hearing loss, respectively, compared with the study’s reference group.Moderate and severe frailty were linked to 66% and 141% higher odds of developing hearing loss, respectively, compared with the study’s reference group.